Effect of ramipril on cardiovascular events in high-risk patients. Reply

被引：0
|
作者：
Yusuf, S [1 ]
机构：
[1] McMaster Univ, Hamilton, ON L8L 2X2, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [21] Vitamin E supplementation and cardiovascular events in high-risk patients
    Yusuf, S
    Dagenais, G
    Pogue, J
    Bosch, J
    Sleight, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (03): : 154 - 160
  • [22] Fasting glucose as a predictor of cardiovascular events in high-risk patients
    Held, C.
    Gerstein, H.
    Zhao, F.
    Hilbrich, L.
    Anderson, C.
    Sleight, P.
    Yusuf, S.
    Teo, K.
    EUROPEAN HEART JOURNAL, 2006, 27 : 171 - 171
  • [23] Peripheral Endothelial Function and Cardiovascular Events in High-Risk Patients
    Matsuzawa, Yasushi
    Sugiyama, Seigo
    Sumida, Hitoshi
    Sugamura, Koichi
    Nozaki, Toshimitsu
    Ohba, Keisuke
    Matsubara, Junichi
    Kurokawa, Hirofumi
    Fujisue, Koichiro
    Konishi, Masaaki
    Akiyama, Eiichi
    Suzuki, Hiroyuki
    Nagayoshi, Yasuhiro
    Yamamuro, Megumi
    Sakamoto, Kenji
    Iwashita, Satomi
    Jinnouchi, Hideaki
    Taguri, Masataka
    Morita, Satoshi
    Matsui, Kunihiko
    Kimura, Kazuo
    Umemura, Satoshi
    Ogawa, Hisao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (06):
  • [24] Effect of PSA on equal treatment of high-risk patients.
    Ferenczi, Basil
    Frankel, Jason
    Jung, Nathan
    Porter, Christopher
    Flores, John Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Ramipril in High-Risk Patients With COVID-19
    Amat-Santos, Ignacio J.
    Santos-Martinez, Sandra
    Lopez-Otero, Diego
    Nombela-Franco, Luis
    Gutierrez-Ibanes, Enrique
    Del Valle, Raquel
    Munoz-Garcia, Erika
    Jimenez-Diaz, Victor A.
    Regueiro, Ander
    Gonzalez-Ferreiro, Rocio
    Benito, Tomas
    Sanmartin-Pena, Xoan Carlos
    Catala, Pablo
    Rodriguez-Gabella, Tania
    Delgado-Arana, Jose Raul
    Carrasco-Moraleja, Manuel
    Ibanez, Borja
    San Roman, J. Alberto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 268 - 276
  • [26] Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events
    Capri, S
    Perlini, S
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 913 - 921
  • [27] Erectile Dysfunction Predicts Cardiovascular Events in High Risk Patients Receiving Telmisartan, Ramipril or Both
    Boehm, Michael
    Baumhaekel, Magnus
    Teo, Keen
    Sleight, Peter
    Probstfleld, Jeffrey
    Gao, Peggy
    Mann, Johannes H.
    Diaz, Rafael
    Dagenais, Gilles R.
    Jennings, Garry L.
    Liu, Lisheng
    Jansky, Petr
    Yusuf, Salim
    CIRCULATION, 2009, 120 (18) : S475 - S475
  • [28] In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events
    Dans, Antonio L.
    Teo, Koon
    Gao, Peggy
    Chen, Jyh-Hong
    Jae-Hyung, Kim
    Yusoff, Khalid
    Chaithiraphan, Suphachai
    Jun Zhu
    Liu Lisheng
    Yusuf, Salim
    PLOS ONE, 2010, 5 (12):
  • [29] Influenza Vaccine Reduces Risk of Adverse Cardiovascular Events in High-Risk Patients
    Slawson, David
    AMERICAN FAMILY PHYSICIAN, 2014, 89 (03) : 224 - +
  • [30] Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients (vol 342, pg 145, 2000)
    De Giorgio, L
    La Tour, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18): : 1376 - 1376
12345